Doxorubicin drug-eluting bead transarterial chemoembolization (DEB-TACE) for patients with hepatocellular carcinoma (HCC)

Source:
Centre for Reviews and Dissemination Health Technology Assessments - CRD HTA
Publisher:
Centre for Reviews and Dissemination
Publication date:
18 August 2012

Abstract

Bibliographic details

 Doxorubicin drug-eluting bead transarterial chemoembolization (DEB-TACE) for patients with hepatocellular carcinoma (HCC). Lansdale: HAYES, Inc.. Healthcare Technology Brief Publication. 2012

Status

This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database.

Indexing status

Subject indexing assigned by CRD

Index terms